Danaher Corp. (DHR): Price and Financial Metrics


Danaher Corp. (DHR): $281.69

4.22 (+1.52%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DHR POWR Grades

  • Sentiment is the dimension where DHR ranks best; there it ranks ahead of 97.83% of US stocks.
  • The strongest trend for DHR is in Quality, which has been heading up over the past 179 days.
  • DHR's current lowest rank is in the Momentum metric (where it is better than 6.78% of US stocks).

DHR Stock Summary

  • With a market capitalization of $198,214,310,330, DANAHER CORP has a greater market value than 99.31% of US stocks.
  • DHR's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 274.7 -- higher than 91.03% of US-listed equities with positive expected earnings growth.
  • DHR's went public 34.86 years ago, making it older than 91.24% of listed US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to DANAHER CORP are TMO, ABT, DIS, BABA, and NVO.
  • DHR's SEC filings can be seen here. And to visit DANAHER CORP's official web site, go to www.danaher.com.

DHR Valuation Summary

  • In comparison to the median Healthcare stock, DHR's EV/EBIT ratio is 153.7% higher, now standing at 27.4.
  • DHR's price/sales ratio has moved up 4.2 over the prior 243 months.

Below are key valuation metrics over time for DHR.

Stock Date P/S P/B P/E EV/EBIT
DHR 2022-09-01 6.5 4.3 32.1 27.4
DHR 2022-08-31 6.4 4.2 31.6 27.0
DHR 2022-08-30 6.5 4.3 32.0 27.3
DHR 2022-08-29 6.5 4.3 32.4 27.6
DHR 2022-08-26 6.6 4.4 32.9 28.0
DHR 2022-08-25 6.9 4.5 34.1 29.0

DHR Growth Metrics

    The 4 year net cashflow from operations growth rate now stands at -0.9%.
  • The 3 year net income to common stockholders growth rate now stands at 160.91%.
  • Its 2 year cash and equivalents growth rate is now at -14.9%.
DHR's revenue has moved up $10,378,700,000 over the prior 33 months.

The table below shows DHR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 30,816 8,335 6,206
2022-03-31 30,283 8,455 6,292
2021-12-31 29,453 8,358 6,269
2021-09-30 28,065.3 8,246.3 5,721.4
2021-06-30 26,719.5 7,935 5,446.8
2021-03-31 24,798.9 7,260 4,595.5

DHR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DHR has a Quality Grade of C, ranking ahead of 42.27% of graded US stocks.
  • DHR's asset turnover comes in at 0.36 -- ranking 56th of 75 Measuring and Control Equipment stocks.
  • IIVI, COHR, and INTT are the stocks whose asset turnover ratios are most correlated with DHR.

The table below shows DHR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-01 0.360 0.604 0.259
2021-07-02 0.353 0.592 0.255
2021-04-02 0.335 0.576 0.221
2020-12-31 0.308 0.560 0.168
2020-10-02 0.267 0.550 0.164
2020-07-03 0.266 0.553 0.164

DHR Price Target

For more insight on analysts targets of DHR, see our DHR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $334.69 Average Broker Recommendation 1.43 (Moderate Buy)

DHR Stock Price Chart Interactive Chart >

Price chart for DHR

DHR Price/Volume Stats

Current price $281.69 52-week high $333.96
Prev. close $277.47 52-week low $233.71
Day low $275.11 Volume 481,571
Day high $281.99 Avg. volume 2,619,336
50-day MA $276.07 Dividend yield 0.36%
200-day MA $279.16 Market Cap 204.91B

Danaher Corp. (DHR) Company Bio


Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are "Life Sciences", "Diagnostics", and "Environmental & Applied Solutions". (Source:Wikipedia)


DHR Latest News Stream


Event/Time News Detail
Loading, please wait...

DHR Latest Social Stream


Loading social stream, please wait...

View Full DHR Social Stream

Latest DHR News From Around the Web

Below are the latest news stories about DANAHER CORP that investors may wish to consider to help them evaluate DHR as an investment opportunity.

Danaher to Webcast Bioprocessing Investor and Analyst Meeting at Cytiva

Danaher Corporation (NYSE: DHR) will host a live video webcast of its Bioprocessing Investor and Analyst Meeting at Cytiva on September 15, 2022 beginning at approximately 12:00 p.m. ET. The event will be held at Danaher's Cytiva facility in Marlborough, Massachusetts and hosted by Rainer M. Blair, President & CEO, and Emmanuel Ligner, Vice President and Biotechnology Group Executive. A link to the webcast and accompanying slide presentation will be available on the "Investors" section of Danahe

Yahoo | September 1, 2022

The Top 5 Growth Stocks That Hedge Funds Are Buying Now

Hedge funds and mutual funds are starting to rotate back into growth stocks, replacing value stocks in the process.

Eddie Pan on InvestorPlace | August 29, 2022

Danaher (DHR) Dips More Than Broader Markets: What You Should Know

Danaher (DHR) closed the most recent trading day at $276.69, moving -1.3% from the previous trading session.

Yahoo | August 29, 2022

A Startup Offers Japan's Aging CEOs a Worry-Free Succession Plan

(Bloomberg) -- Like most aging chief executives in Japan, Sadatsugu Kishida had a list of demands before handing over the reins of his company.Most Read from BloombergLukoil Chairman Ravil Maganov Dies After Falling From Hospital WindowPutin Brings China and India to Russia for War Games Defying USHong Kong Officials Target End to Hotel Quarantine in NovemberJeremy Grantham Warns ‘Super Bubble’ in Stocks Has Yet to Burst“No job cuts. No company name change. You must understand and inherit my phi

Yahoo | August 29, 2022

Here's Why Investors Should Retain Danaher (DHR) Stock for Now

Danaher (DHR) is benefiting from strength in its Life Sciences segment, acquisitions and shareholder-friendly actions despite supply-chain challenges and escalating costs.

Yahoo | August 25, 2022

Read More 'DHR' Stories Here

DHR Price Returns

1-mo -1.24%
3-mo 12.13%
6-mo 7.51%
1-year -14.50%
3-year 104.45%
5-year 232.37%
YTD -14.22%
2021 48.57%
2020 45.34%
2019 49.55%
2018 11.80%
2017 20.01%

DHR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full DHR Dividend History

Continue Researching DHR

Want to see what other sources are saying about Danaher Corp's financials and stock price? Try the links below:

Danaher Corp (DHR) Stock Price | Nasdaq
Danaher Corp (DHR) Stock Quote, History and News - Yahoo Finance
Danaher Corp (DHR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.6219 seconds.